The bill is coming due. Across England, the financial strain of meeting an unprecedented demand for ADHD and autism assessments has hit a breaking point. Local health leaders are sounding alarms. Budgets are buckling under the weight.
If you've tried navigating the public healthcare system for a neurodivergence evaluation lately, you already know the system is broken. Years-long waiting lists forced sweeping policy changes. Patients gained the legal right to choose any qualified provider. Private companies rushed in to fill the massive vacuum. Now, NHS integrated care boards are footing a wildly inflated bill, and the math simply doesn't add up anymore.
Let's look at what's actually happening on the ground.
The Numbers Tell a Brutal Story
Spending hasn't just crept up. It exploded.
Recent data compiled by the NHS Alliance exposes staggering financial jumps. One integrated care board watched its monthly expenditure for these specific services rocket from £146,000 to a staggering £1.5 million in just one year. Another board saw its adult ADHD budget leap from £11 million to a projected £51 million.
Multiply that chaos across the country. Local commissioners find themselves trapped in an impossible squeeze. They must fund legally mandated care, yet they have zero control over how private entities price their services.
Why did this happen? Simple supply and demand economics met a rigid, unprepared public infrastructure.
When millions of adults and parents of struggling children realized they could bypass endless NHS queues using patient choice rules, independent clinics opened overnight. Some local patches suddenly found themselves dealing with up to 80 different external suppliers.
Competition is supposed to drive down prices. It did the exact opposite here.
The Wild West of Private Providers
Without a centralized pricing structure, the market turned chaotic. Local boards report paying anywhere from £300 to a staggering £3,000 for identical assessment services depending on which provider they use.
That is not just inefficient. It's fiscally reckless.
Many of these new market entrants operate as small, unregulated setups. They specialize in ticking boxes for diagnoses, but they offer zero long-term clinical management or follow-up support. Patients get a piece of paper confirming what they already knew, but they're left stranded with no actual medical pathways or ongoing treatment.
Local health managers are caught in a brutal bind. Cut other vital community health services to pay for exploding neurodivergence bills, or let waiting lists stretch into a decade. Neither option works. Both fail patients.
What Needs to Change Right Now
Throwing more money at a fragmented market fixes nothing. NHS leaders are pushing for immediate structural fixes, and honestly, it's long overdue.
First, England desperately needs a national mandatory price ceiling or tariff for these services. Private providers shouldn't be allowed to charge arbitrary sums just because a local health board is legally cornered into paying.
Second, uniform clinical standards must apply everywhere. A diagnosis should mean the same thing whether you get it in Cornwall or Cumbria. Right now, the variance in quality control creates a postcode lottery that leaves vulnerable people at the mercy of whichever vendor has the slickest marketing team.
The current trajectory is unsustainable. Taxpayers are footing an unmonitored bill, and patients are getting a fragmented, stressful experience. Fixing this isn't just about balancing spreadsheets. It's about building a healthcare framework that actually functions without crashing the entire system.
